Moreover, high levels of TSPAN3 positively correlated with poor differentiation, lymph node involvement, advanced pathological tumor-node-metastasis stage, and poor prognosis in patients with NSCLC. This evidence concerns the gene TSPAN3 and non-small cell lung carcinoma.